Aiweixin, a Traditional Uyghur Medicinal Formula, Extends the Lifespan of<i> Caenorhabditis elegans</i>

Zhu, Binggen; Jo, Kayama; Yang, Ping; Tohti, Jurat; Fei, Jian; Abudukerim, Kaisaier

doi:https://doi.org/10.1155/2019/3684601

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Background Methods Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 3684601 | https://doi.org/10.1155/2019/3684601

Aiweixin, a Traditional Uyghur Medicinal Formula, Extends the Lifespan of Caenorhabditis elegans

Binggen Zhu,^1,2Kayama Jo,²Ping Yang,³Jurat Tohti,¹Jian Fei,^3,4and Kaisaier Abudukerim¹

Academic Editor: Omer Kucuk

Received15 Mar 2018

Revised05 Sept 2018

Accepted14 Nov 2018

Published13 Jan 2019

Abstract

Aiweixin (AWX) is a traditional Uyghur medicine prescription, which has been used to treat senile diseases for a long time. We investigate whether the AWX extends the lifespan of Caenorhabditis elegans. The AWX decoction was the conventional product for clinical use. The wild-type Caenorhabditis elegans (N2) and mutational worms, daf-16(mu86), glp-1(e2141), daf-2(e1370), and eat-2(ad465), were applied for the lifespan analysis. We found that the lifespan of the N2 adults' worm received 0.005 and 0.01 volume of AWX/total volume was extended significantly, compared to the control without treatment of AWX. The AWX at 0.01 volume of AWX/total volume significantly prolonged the life of both mutational worms, daf-16 (mu86) and eat-2(ad465), but did not increase the lifespan of the mutational worms, daf-2(e1370) and glp-1(e2141). These results indicated that the AWX significantly extended the lifespan of wild-type nematodes, and the life extension effect of AWX was related to the germline longevity pathway and IIS signaling pathway but independent of DAF-16/FOXO.

1. Background

The nematode Caenorhabditis elegans is a popular model organism used in biomedical fields, because of its transparent body, short life span, ease of maintenance and genetic manipulation, and amenability to high-throughput screening [1]. The worm possesses genes homologous to two-thirds of those involved in human disease and the signaling pathways controlling the aging process are conserved between Caenorhabditis elegans and humans [2–4]. These features make it an ideal model for aging research and assessing compounds that can increase stress resistance and/or even promote healthy aging in humans [4–7]. Increasing studies disclosed that some of Chinese medicinal herbs and most of secondary plant compounds influence ageing, stress resistance, and distinct signaling pathways in the nematodes [5–8].

Aiweixin (AWX) is a traditional Uyghur medicine prescription, which has been used to treat heart diseases, neuropsychiatric disorders (such as depression) and senile diseases for a long time [9–12]. AWX consists of 15 ingredients including Dracocephalum moldavicum L., Eletteria cardamomum (L.) Maton, Salix caprea L. (Salicaceae) flowers, Lavandula augustifolia (lavender), Borago officinalis L. (Boraginaceae) stems and leaves, Borago officinalis L. (Boraginaceae) flower, Nardostachys jatamansi DC. root and rhizome (Nardostachyos Radix et Rhizoma), Bombyx mori (Abresham) silk cocoons, Usnea longissima Ach., Rosa rugosa Thunb. flowers, Syzygium aromaticum L., Lindera caudata (Nees) Hook.f., Myristica fragrans (Houtt.), and Crocus sativus L. and Moschus [8]. The HPLC fingerprint of AWX showed 4 large peaks, by using HPLC–UV-ESI-TOF-MS system. Peaks 1-4 contain chebulic acid, gallic acid, protocatechuic acid, and eugenol, respectively [13].

Previous experiments demonstrated that therapeutic effects of AWX in a rat model of myocardial ischemia reperfusion injury were possibly via alleviation of oxidative stress [14, 15], and the antioxidative defense mechanisms were involved in the protective action of AWX against the toxicity of chromium (VI) in Caenorhabditis elegans [13]. The aim of this work was to investigate the lifespan-extending effects of AWX and study the possible mechanisms by which AWX delays the aging process in Caenorhabditis elegans. For this purpose, wild-type (N2) and several mutational worms, such as daf-16 (mu86), glp-1(e2141), daf-2 (e1370), and eat-2 (ad465), were used in our studies. These mutational lines would help us to search several known signaling pathways which were involved in the aging of nematodes [4].

2. Methods

2.1. Preparation of AWX

The AWX decoction was the conventional product for clinical use, manufactured by Xinwei Pharmaceutical Factory (Hetian, Xinjiang Uygur Autonomous Region, PR China). According to the Pharmacopeia of PR China [7], the product is made from Dracocephalum moldavicum L. (15 g), Eletteria cardamomum (L.) Maton (15 g), Salix caprea L. (Salicaceae) flowers (10 g), Lavandula augustifolia (lavender) (15 g), Borago officinalis L. (Boraginaceae) stems and leaves (10 g), Borago officinalis L. (Boraginaceae) flower (10 g), Nardostachys jatamansi DC. root and rhizome (Nardostachyos Radix et Rhizoma) (10 g), Bombyx mori (Abresham) silk cocoons (50 g), Usnea longissima Ach. (3 g), Rosa rugosa Thunb. flowers (15 g), Syzygium aromaticum L. (15 g), Lindera caudata (Nees) Hook.f. (10 g), Myristica fragrans (Houtt.) (15 g), Crocus sativus L. (0.6 g), and Moschus (0.2 g). The AWX decoction was prepared as described elsewhere [13].

2.2. Caenorhabditis elegans Strain and Maintenance

The wild-type Caenorhabditis elegans strain N2 (Bristol) and mutational worms, daf-16 (mu86), glp-1(e2141), daf-2 (e1370), and eat-2 (ad465), were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN). Nematodes were generally incubated at 20°C on nematode growth media (NGM) plates with E. coli OP50. For culture of daf-2 (e1370) and its wild-type control, nematodes were firstly developed at 16°C for 3 days and then transferred to 20°C for the desired stage of development.

2.3. Lifespan Analysis

The lifespan assay was performed basically as described elsewhere [16]. Age-synchronized day 1 adult N2 and mutational nematodes were transferred to a 96-well plate with 1-2 worms in 80μL of S-complete liquid medium containing various AWX drug concentrations (0.001, 0.005, 0.01, 0.05 volume of AWX/total volume, respectively) in each well. E. coli OP50 and FUDR were added to the medium. Therefore, AWX treatment was applied throughout the whole life of the worms since day 1. Plates were sealed with tape (Nunc) to prevent evaporation. Then the temperature was shifted from 20°C to 25°C. Survival was assessed every day or every other day until death using the touch-provoked method. The fraction of animals alive was scored using a microscope on the basis of movement. The nematodes were considered dead when they failed to respond to touch using a platinum loop. The lifespan assay was repeated in three independent trails.

2.4. Statistical Analyses

GraphPad Prism 6.01 was used for statistical analyses. For the lifespan assay, Kaplan-Meier survival analysis was conducted, and p values were calculated using the log-rank (Mantel-Cox) test. Values of P < 0.05 were considered significant.

3. Result

3.1. The Effect of AWX on the Lifespan of Wild Type Caenorhabditis elegans

As shown in Figure 1 & Table 1, the lifespan of the N2 adults’ worm received AWX at 0.005 (18.296 ± 0.422) and 0.01 (17.130 ± 0.414) was extended significantly, compared to the control without treatment of AWX (15.506 ± 0.447, p<0.0001 and p=0.0091, respectively). The increasing percentages of AWX at 0.005 and 0.01, compared to the control, were 17.99% and 10.47%, respectively. The effect of AWX was seen since 11 day and was basically in a dose-dependent manner. AWX at 0.001 did not extend significantly the lifespan of Caenorhabditis elegans compared to the control (16.333 ± 0.621 vs 15.506 ± 0.447, and p=0.2726), whereas the lifespan of worms rthat eceived AWX at 0.05 was significantly lower than the one of the control without treatment of AWX (10.565 ± 0.277 vs 15.506 ± 0.447, p<0.0001). All worms were dead at 17 day of experiment with the treatment of 0.05 AWX, while some worms were still alive at 23 day of experiment in other groups (Figure 1 & Table 1). Therefore, AWX at high doses was quite harmful for the survival of nematodes.

Figure 1

Effects of AWX on the lifespan of wild-type N2 nematodes. The data were presented in Table 1. The lifespan of the N2 adults’ worm received AWX at 0.005 and 0.01 was extended significantly, compared to the control without treatment of AWX (p<0.0001 and p=0.0091, respectively). Whereas the lifespan of worms received AWX at 0.05 was significantly lower than the one of the control without treatment of AWX (p<0.0001). All worms were dead at 17 day of experiment with the treatment of 0.05 AWX, while some worms were still alive at 23 day of experiment in other groups.

3.2. The Lifespan-Extending Effects of AWX Was DAF-2 and GLP-1 Dependent, but EAT-2 and DAF-16 Independent

As shown in Table 2, the lifespan-extending effects of AWX were not seen in the mutational worms, daf-2(e1370) and glp-1(e2141). The lifespan of daf-2(e1370) and glp-1(e2141) received AWX at 0.01 was not significantly different from the one in control without treatment of AWX (35.34 ± 1.200 vs 33.88 ± 0.9682, p=0.2696; 18.30 ± 0.2490 vs 18.26 ± 0.3969, p=0.8184). AWX at 0.01 slightly increased the lifespan of the mutational worms, daf-2(e1370), but the effect did not reach significant level. Therefore, the lifespan-extending effects of AWX should be DAF-2 and GLP-1 dependent.

However, the lifespan of daf-16 (mu86) and eat-2(ad465) received AWX at 0.01 was significantly higher than the one in control without treatment of AWX (16.09 ± 0.3302 vs 12.67 ± 0.2814, p<0.0001; 33.31 ± 0.5561 vs 28.36 ± 0.5138, p<0.0001). The increasing percentages with the treatment of AWX at 0.01, compared to the control, were 26.99% and 17.45%, respectively. AWX at 0.01 significantly prolonged the life of both mutational worms, daf-16 (mu86) and eat-2(ad465). In the consequence of results, the lifespan-extending effects of AWX were independent of both DAF-16/FOXO and EAT-2.

4. Discussion

Recently, Zhao et al. identify two forms of death in ageing Caenorhabditis elegans [17]. The first form, “P death” which showed severe swelling of the posterior pharyngeal bulb, is associated with pharyngeal invasion and proliferation of bacteria and mainly occurred in mid adulthood (at mean age of 12 days). The antibiotic, Carbenicillin, that was used to treat bacteria which were food for worms, significantly reduced the P death in midlife [17]. According to the phytochemical analysis of AWX by high-performance liquid chromatography-diode array detection (HPLC-DAD), the eugenol and gallic acid were identified in the second and third high peaks of AWX, respectively [13]. The eugenol attenuated the virulence of enterohemorrhagic Escherichia coli O157:H7 (EHEC) [18]. Eugenol at 0.005% prolonged Caenorhabditis elegans survival in the presence of EHEC. The gallic acid increased the longevity of worm only in the presence of live bacteria, but not dead bacteria, depending on its antibacterial capacities [19]. Therefore, it is not impossible that the decline of P death by the eugenol and gallic acid in the AWX might be one of mechanisms which promote the survival of nematodes. Moreover, researchers also found that eugenol at high doses exhibited nematicidal activity in the Caenorhabditis elegans model [20, 21], which may explain the toxic effect of high concentration of AWX for the worms in our previous [13] and present experiments.

Another form of death in ageing Caenorhabditis elegans is the “p death,” which showed marked atrophy of the posterior pharyngeal bulb, presented an exponential increase in mid-to-late life (at mean age of 22 days) [17]. We found that AWX prolonged the lifespan of eat-2(ad465) mutant, although the lifespan already extended in eat-2 mutant compared to the wild type. The lifespan extension observed in the eat-2 mutant was largely attributable to reduction in the frequency of P death, according to the studies of Zhao et al. [17]. Hence, it is possible that AWX might not only protect worms from bacteria invasion and reduce the P death, but also exerted genuine anti-aging effects and lessened the p death, thus leading to that the eat-2 mutant lived much longer at the appropriate doses of AWX. On the other hand, Zhao et al. found that the increase lifespan of Caenorhabditis elegans in germline defective mutant glp-1 was, to a large extent, attributed to delaying of “p death” [17]. Our studies showed the lifespan extension effect of AWX was removed in the glp-1(e2141) mutant, highlighting that holding off “p death” should be the important route by which AWX promote the survival of nematodes. It is noteworthy that the glp-1mutant that induces germline depletion enhances the resistance of worms to pathogenic bacteria [22]. The effect was recently found to be involved in the activation an innate immunity related gene, named irg-7, which might be a novel mediator of longevity in germlineless animals [23].

The most unintentional finding in our study was that AWX exposures led to significantly prolonged lifespan in daf-16 (mu86) mutants, but not in daf-2(e1370) mutants, indicating that the described AWX effects did not depend on DAF-16/FOXO activity, although it was in a DAF-2/insulin/IGF-1 receptor-dependent manner, to some extent. So far, three most important downstream lifespan-regulatory transcription factors of insulin/IGF-1 signaling (IIS) pathway in Caenorhabditis elegans that have been identified are DAF-16/FOXO, heat shock transcription factor 1 (HSF-1), and SKN-1/nuclear factor erythroid 2 (NRF2) [24, 25]. Therefore, HSF-1 and/or SKN-1 might be responsible for the effect of AWX. Besides DAF-16/FOXO, HSF-1, or SKN-1 also are essential for the longevity of animals with reduced IIS [24, 25]. HSF-1 binds to specific regions of DNA containing heat shock elements, and triggers the induction of genes encoding molecular chaperones, such as HSP-70 and HSP-16, whose overexpression extends lifespan [26]. Thus, HSF-1 appears to lead to longevity by upregulating the chaperone network that enhances the proper folding of various proteins [23, 24]. Over expression of constitutively nuclear SKN-1 extends lifespan in a DAF-16/FOXO-independent manner [27]. SKN-1, an oxidative stress-responsive NRF transcription factor, mediates the expression of genes involved in detoxification and stress responses, and promotes protein homeostasis through regulating proteasome production, which contributes to a longer lifespan [23, 24, 26]. Meanwhile, in addition to DAF-16/FOXO, other pathways, such as steroidal hormone signaling and innate immune response, may play an important role in the lifespan-extending effects of germline removal. Reduction-of-function mutations in the gene daf-12, which encodes a nuclear hormone receptor (NHR), or in genes like daf-9, which encode proteins that synthesize sterol ligands for DAF-12, prevent loss of the germline from extending lifespan [28, 29].

Future lifespan assays with various Caenorhabditis elegans mutants and RNAi strains as well as gene expression profile via RT-PCR will reveal whether or not the HSF-1, SKN-1, DAF-12, DAF-9, and IRG-7 pathway are responsible for the observed AWX effects. Moreover, complete quantitative phytochemical studies of the AWX, measuring pharyngeal pumping rate and longitudinal pathology analysis on individual worms and using dead bacteria previously treated by antibiotics as food for worms, would be helpful to seek mechanisms of the lifespan extension effect of AWX.

5. Conclusion

In conclusion, the AWX significantly extended the lifespan of wild-type nematodes. Further studies on several Caenorhabditis elegans mutants indicated that the lifespan extension effect of AWX was related to the germline longevity pathway and IIS signaling pathway but independent of DAF-16/FOXO.

Data Availability

The data (in the form of PZFX file) used to support the findings of this study are available from the corresponding author upon request. GraphPad Prism 6.01 was used for statistical analyses.

Conflicts of Interest

All of authors declare no conflicts of interest.

Authors’ Contributions

Binggen Zhu and Kayama Jo contributed equally to this work. Binggen Zhu, Jian Fei, and Kaisaier Abudukerim conceived and designed the study. Kayama Jo and Ping Yang performed the experiments and analyzed data. Binggen Zhu wrote the manuscript. Binggen Zhu, Kayama Jo, and Jurat Tohti searched and reviewed the literature. Jurat Tohti supplied the genuine AWX.

Acknowledgments

The work was supported by the Science and Technology Support Project of Xinjiang Uyghur Autonomous Region (201233147), China, and the Discipline Construction Project of Health and Family Planning Commission of Pudong New Area (PWYgy2018-10), Shanghai, China.

References

L. P. O'Reilly, C. J. Luke, D. H. Perlmutter, G. A. Silverman, and S. C. Pak, “C. elegans in high-throughput drug discovery,” Advanced Drug Delivery Reviews, vol. 69-70, pp. 247–253, 2014.
View at: Publisher Site | Google Scholar
A. Antebi, “Genetics of aging in Caenorhabditis elegans,” PLoS Genetics, vol. 3, no. 9, pp. 1565–1571, 2007.
View at: Google Scholar
H. A. Tissenbaum, “Genetics, life span, health span, and the aging process in caenorhabditis elegans,” Journals of Gerontology. Series A, Biological Sciences & Medical Sciences, vol. 67, no. 5, pp. 503–510, 2012.
View at: Publisher Site | Google Scholar
A. Olsen, M. C. Vantipalli, and G. J. Lithgow, “Using Caenorhabditis elegans as a model for aging and age-related diseases,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 120–128, 2006.
View at: Publisher Site | Google Scholar
Q. Wang, F. Yang, W. Guo et al., “Caenorhabditis elegans in Chinese medicinal studies: making the case for aging and neurodegeneration,” Rejuvenation Research, vol. 17, no. 2, pp. 205–208, 2014.
View at: Publisher Site | Google Scholar
F. Wan, D. Zhi, D. Liu et al., “Lifespan extension in Caenorhabiditis elegans by several traditional Chinese medicine formulas,” Biogerontology, vol. 15, no. 4, pp. 377–387, 2014.
View at: Publisher Site | Google Scholar
J. J. Collins, K. Evason, and K. Kornfeld, “Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans,” Experimental Gerontology, vol. 41, no. 10, pp. 1032–1039, 2006.
View at: Publisher Site | Google Scholar
K. Koch, S. Havermann, C. Büchter, and W. Wätjen, “Caenorhabditis elegans as model system in pharmacology and toxicology: Effects of flavonoids on redox-sensitive signalling pathways and ageing,” The Scientific World Journal, vol. 2014, Article ID 920398, 15 pages, 2014.
View at: Google Scholar
China Pharmacopoeia Commission, Drug Standard of Ministry of Public Health of the Peoples Republic of China (Uyghur Medicine), vol. 72, Xinjiang publishing house of science, technology and health, Urumqi, China, 1999.
T. Jurat, A. Tuehong, and Q. Wu, “The clinical efficacy research of Aiweixin oral liquor in the treatment of coronary heart disease and myocardial ischemia,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 15, no. 4, pp. 10–13, 2009.
View at: Google Scholar
A. Dilinul and H. Asya, “Uyghur medical guidelines for diagnosis and treatment of malihuliya (depression),” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 17, no. 9, pp. 50-51, 2011.
View at: Google Scholar
H. Asya, A. Dilinul, and H. Maimaiti, “Uyghur medical guidelines for diagnosis and treatment of cerebral infarction,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 16, no. 12, pp. 74-75, 2010.
View at: Google Scholar
B. Zhu, P. Yang, N. Mammat et al., “Aiweixin, a traditional Uyghur medicinal formula, protects against chromium toxicity in Caenorhabditis elegans,” BMC Complementary and Alternative Medicine, vol. 15, p. 285, 2015.
View at: Publisher Site | Google Scholar
R. Wang, L. Wang, and Y. Liu, “Research on the protective effects of Aiweixin ischemia-reperfusion injury in liquid in myocardial rats,” Journal of Xinjiang Medical University, vol. 32, pp. 146–149, 2009.
View at: Google Scholar
Y. M. Yuan, L. Wang, and R. Wang, “Influence of Aiweixin oral liquor on MPO and MDA in MIRI rat,” Journal of Xinjiang Medical University, vol. 33, pp. 33–35, 2010.
View at: Google Scholar
F. Meng, J. Li, W. Wang, and Y. Fu, “Gengnianchun, a Traditional Chinese Medicine, Enhances Oxidative Stress Resistance and Lifespan in Caenorhabditis elegans by Modulating daf-16/FOXO,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8432306, 10 pages, 2017.
View at: Publisher Site | Google Scholar
Y. Zhao, A. F. Gilliat, M. Ziehm et al., “Two forms of death in ageing Caenorhabditis elegans,” Nature Communications, vol. 8, Article ID 15458, 2017.
View at: Publisher Site | Google Scholar
Y. Kim, J. Lee, G. Gwon, S. Kim, J. G. Park, and J. Lee, “Essential Oils and Eugenols Inhibit Biofilm Formation and the Virulence of Escherichia coli O157:H7,” Scientific Reports, vol. 6, no. 1, Article ID 36377, 2016.
View at: Publisher Site | Google Scholar
N. Saul, K. Pietsch, S. R. Stürzenbaum, R. Menzel, and C. E. Steinberg, “Diversity of polyphenol action in Caenorhabditis elegans: between toxicity and longevity,” Journal of Natural Products, vol. 74, no. 8, pp. 1713–1720, 2011.
View at: Google Scholar
F. H. Abdel-Rahman, N. M. Alaniz, and M. A. Saleh, “Nematicidal activity of terpenoids,” Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and Agricultural Wastes, vol. 48, no. 1, pp. 16–22, 2013.
View at: Publisher Site | Google Scholar
M. Asha, D. Prashanth, B. Murali, R. Padmaja, and A. Amit, “Anthelmintic activity of essential oil of Ocimum sanctum and eugenol,” Fitoterapia, vol. 72, no. 6, pp. 669-670, 2001.
View at: Publisher Site | Google Scholar
S. Alper, M. K. McElwee, J. Apfeld, B. Lackford, J. H. Freedman, and D. A. Schwartz, “The Caenorhabditis elegans germ line regulates distinct signaling pathways to control lifespan and innate immunity,” The Journal of Biological Chemistry, vol. 285, no. 3, pp. 1822–1828, 2010.
View at: Publisher Site | Google Scholar
E. Yunger, M. Safra, M. Levi-Ferber, A. Haviv-Chesner, S. Henis-Korenblit, and M. Tan, “Innate immunity mediated longevity and longevity induced by germ cell removal converge on the C-type lectin domain protein IRG-7,” PLoS Genetics, vol. 13, no. 2, Article ID e1006577, 2017.
View at: Publisher Site | Google Scholar
O. Altintas, S. Park, and S.-J. V. Lee, “The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster,” BMB Reports, vol. 49, no. 2, pp. 81–92, 2016.
View at: Publisher Site | Google Scholar
C. T. Murphy and P. J. Hu, “Insulin/insulin-like growth factor signaling in C. elegans,” WormBook, pp. 1–43, 2013.
View at: Publisher Site | Google Scholar
M. J. Muñoz, “Longevity and heat stress regulation in Caenorhabditis elegans,” Mechanisms of Ageing and Development, vol. 124, no. 1, pp. 43–48, 2003.
View at: Publisher Site | Google Scholar
J. M. A. Tullet, M. Hertweck, J. H. An et al., “Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans,” Cell, vol. 132, no. 6, pp. 1025–1038, 2008.
View at: Publisher Site | Google Scholar
C. Kenyon, “A pathway that links reproductive status to lifespan in Caenorhabditis elegans,” Annals of the New York Academy of Sciences, pp. 1204–156, 2010.
View at: Google Scholar
B. Gerisch, V. Rottiers, D. Li et al., “A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 104, no. 12, pp. 5014–5019, 2007.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Binggen Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

878

Downloads

746

Citations